Non-coding RNAs to regulate cardiomyocyte proliferation: A new trend in therapeutic cardiac regeneration

Kele Qin1, Xiaohui Xie1, Weijie Tang1

  • 1Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Insights

Cardiovascular diseases cause irreversible heart damage. This review explores non-coding RNAs (ncRNAs) for cardiomyocyte regeneration and potential myocardial infarction therapies.

Area of Science:

  • Biomedical research
  • Regenerative medicine
  • Cardiology

Background:

  • Cardiovascular diseases, especially ischemic heart disease (IHD), are leading global causes of death.
  • IHD causes irreversible damage to cardiomyocytes, making myocardial regeneration a critical research area.
  • The mammalian heart's regenerative capacity diminishes with age, unlike in embryonic/neonatal stages.

Purpose of the Study:

  • To review recent advancements in cardiomyocyte regenerative medicine.
  • To elucidate the biological functions and mechanisms of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in cardiomyocyte posttranscriptional regulation.
  • To summarize the roles of ncRNAs in different species and explore therapeutic strategies for myocardial infarction.

Main Methods:

  • Literature review of recent research on ncRNAs and cardiac regeneration.
  • Analysis of biological functions and regulatory mechanisms of miRNAs, lncRNAs, and circRNAs.
  • Synthesis of data on species-specific ncRNA roles and therapeutic applications.

Main Results:

  • Non-coding RNAs (ncRNAs) are pivotal in regulating cardiomyocyte regeneration.
  • Specific miRNAs, lncRNAs, and circRNAs influence posttranscriptional processes in cardiomyocytes.
  • ncRNAs exhibit species-specific roles in cardiac repair and regeneration.

Conclusions:

  • ncRNAs offer promising therapeutic targets for cardiomyocyte regeneration and treating myocardial infarction.
  • Understanding ncRNA mechanisms is crucial for developing effective regenerative strategies.
  • Targeting ncRNAs could restore the heart's regenerative potential after injury.

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
987